These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 34867436)
1. Dysbiosis in the Human Microbiome of Cholangiocarcinoma. Rao B; Ren T; Wang X; Wang H; Zou Y; Sun Y; Liu S; Ren Z; Yu Z Front Physiol; 2021; 12():715536. PubMed ID: 34867436 [TBL] [Abstract][Full Text] [Related]
2. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis. Re OL; López-López V; Balaguer-Román A; Martínez-Sánchez MA; Eshmuminov D; Llamoza-Torres CJ; Miura K; Baroja-Mazo A; Ramírez P; Robles-Campos R; Ramos-Molina B Langenbecks Arch Surg; 2023 Mar; 408(1):134. PubMed ID: 37000331 [TBL] [Abstract][Full Text] [Related]
3. Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma. Saab M; Mestivier D; Sohrabi M; Rodriguez C; Khonsari MR; Faraji A; Sobhani I PLoS One; 2021; 16(3):e0247798. PubMed ID: 33690612 [TBL] [Abstract][Full Text] [Related]
4. Helicobacter Species are Possible Risk Factors of Cholangiocarcinoma. Kaewpitoon SJ; Loyd RA; Rujirakul R; Panpimanmas S; Matrakool L; Tongtawee T; Kootanavanichpong N; Pengsaa P; Kompor P; Chavengkun W; Kujapun J; Norkaew J; Ponphimai S; Padchasuwan N; Polsripradist P; Eksanti T; Phatisena T; Kaewpitoon N Asian Pac J Cancer Prev; 2016; 17(1):37-44. PubMed ID: 26838240 [TBL] [Abstract][Full Text] [Related]
5. [Microbiome and Biliary Tract Cancer]. Park JS Korean J Gastroenterol; 2024 Jan; 83(1):1-5. PubMed ID: 38268162 [TBL] [Abstract][Full Text] [Related]
6. Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients. Dangtakot R; Intuyod K; Ahooja A; Wongwiwatchai J; Hanpanich P; Lulitanond A; Chamgramol Y; Pinlaor S; Pinlaor P Asian Pac J Cancer Prev; 2021 Jan; 22(1):233-240. PubMed ID: 33507704 [TBL] [Abstract][Full Text] [Related]
7. SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma. Merino-Azpitarte M; Lozano E; Perugorria MJ; Esparza-Baquer A; Erice O; Santos-Laso Á; O'Rourke CJ; Andersen JB; Jiménez-Agüero R; Lacasta A; D'Amato M; Briz Ó; Jalan-Sakrikar N; Huebert RC; Thelen KM; Gradilone SA; Aransay AM; Lavín JL; Fernández-Barrena MG; Matheu A; Marzioni M; Gores GJ; Bujanda L; Marin JJG; Banales JM J Hepatol; 2017 Jul; 67(1):72-83. PubMed ID: 28237397 [TBL] [Abstract][Full Text] [Related]
8. The role of tumour microenvironment: a new vision for cholangiocarcinoma. Chen Z; Guo P; Xie X; Yu H; Wang Y; Chen G J Cell Mol Med; 2019 Jan; 23(1):59-69. PubMed ID: 30394682 [TBL] [Abstract][Full Text] [Related]
9. The possible mechanisms of the human microbiome in allergic diseases. Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907 [TBL] [Abstract][Full Text] [Related]
11. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma. Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439 [TBL] [Abstract][Full Text] [Related]
12. Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy. Ye C; Dong C; Lin Y; Shi H; Zhou W Microorganisms; 2023 Oct; 11(10):. PubMed ID: 37894256 [TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori Infection, the Gastric Microbiome and Gastric Cancer. Pereira-Marques J; Ferreira RM; Pinto-Ribeiro I; Figueiredo C Adv Exp Med Biol; 2019; 1149():195-210. PubMed ID: 31016631 [TBL] [Abstract][Full Text] [Related]
15. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma. Voigtländer T; Metzger J; Husi H; Kirstein MM; Pejchinovski M; Latosinska A; Frantzi M; Mullen W; Book T; Mischak H; Manns MP J Biomed Sci; 2020 Jan; 27(1):13. PubMed ID: 31900160 [TBL] [Abstract][Full Text] [Related]
16. Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker. Chiang KC; Yeh TS; Wu RC; Pang JS; Cheng CT; Wang SY; Juang HH; Yeh CN Sci Rep; 2016 Oct; 6():36138. PubMed ID: 27782193 [TBL] [Abstract][Full Text] [Related]
17. Yang L; Zhang J; Xu J; Wei X; Yang J; Liu Y; Li H; Zhao C; Wang Y; Zhang L; Gai Z Front Cell Infect Microbiol; 2019; 9():375. PubMed ID: 31781514 [No Abstract] [Full Text] [Related]
18. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma. Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia Inducible Factor-1α: The Curator of Gut Homeostasis. Kumar T; Pandey R; Chauhan NS Front Cell Infect Microbiol; 2020; 10():227. PubMed ID: 32500042 [TBL] [Abstract][Full Text] [Related]
20. The significance of genetics for cholangiocarcinoma development. Maroni L; Pierantonelli I; Banales JM; Benedetti A; Marzioni M Ann Transl Med; 2013 Oct; 1(3):28. PubMed ID: 25332972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]